| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1460215 |
Neotame Related Compound A (15 mg) (N-[N-(3,3-Dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine) |
190910-14-6 |
|
| 2924296000 |
|
|
|
| USP-1460317 |
Nepafenac (200 mg) |
78281-72-8 |
UN2811 |
| USP-1460328 |
Nepafenac Related Compound A (25 mg) (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide) |
1246956-18-2 |
|
| 2924296000 |
|
|
|
| USP-1460339 |
Nepafenac Related Compound B (25 mg) (7-Benzoylindolin-2-one) |
51135-38-7 |
|
| 2933790002 |
|
|
|
| USP-1460500 |
Netilmicin Sulfate (500 mg) |
56391-57-2 |
|
| 2941906000 |
|
|
|
| USP-1460703 |
Nevirapine Anhydrous (100 mg) |
129618-40-2 |
|
| 2933994600 |
|
|
|
| USP-1460714 |
Nevirapine Hemihydrate (100 mg) |
N/A |
|
| 2933994600 |
|
|
|
| USP-1460725 |
Nevirapine Related Compound A (15 mg) (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one) |
133627-17-5 |
UN2811 |
| USP-1460736 |
Nevirapine Related Compound B (10 mg) (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one) |
N/A |
UN2811 |
| USP-1460747 |
Nevirapine Related Compound C (15 mg) (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1461003 |
Niacin (200 mg) |
59-67-6 |
|
| 2936291600 |
|
|
|
| USP-1469005 |
Norethindrone (200 mg) |
68-22-4 |
|
| 2937230000 |
|
|
|
| USP-1470004 |
Norethindrone Acetate (100 mg) |
51-98-9 |
|
| 2937230000 |
|
|
|
| USP-1471506 |
Norfloxacin (200 mg) |
70458-96-7 |
|
| 2933595960 |
|
|
|
| USP-1471517 |
Norfloxacin Related Compound A (15 mg) (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) |
68077-26-9 |
|
| 2933599550 |
|
|
|
| USP-1471550 |
Norfloxacin Related Compound E (15 mg) (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) |
75001-78-4 |
|
| 2933599550 |
|
|
|
| USP-1471583 |
Norfloxacin Related Compound H (15 mg) (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) |
105440-01-5 |
|
| 2933599550 |
|
|
|
| USP-1471619 |
Norfloxacin Related Compound K (15 mg) (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) |
70459-07-3 |
|
| 2933599550 |
|
|
|
| USP-1471914 |
Norgestimate (200 mg) |
35189-28-7 |
|
| 2937230000 |
|
|
|
| USP-1471925 |
Norgestimate Related Compound A (25 mg) (Levonorgestrel Acetate) |
13732-69-9 |
|
| 2937230000 |
|
|
|
| USP-1471958 |
Deacetylnorgestimate (25 mg) ((E)- and (Z)-17-deacetyl norgestimate mixture) |
53016-31-2 |
|
| 2937230000 |
|
|
|
| USP-1472000 |
Norgestrel (125 mg) |
6533-00-2 |
|
| 2937230000 |
|
|
|
| USP-1472043 |
Norgestrel Related Compound L (25 mg) (13-Ethylgon-4-ene-3,17-dione) |
21800-83-9 |
UN3077 |
| USP-1473206 |
Norphenylephrine Hydrochloride (25 mg) |
4779-94-6 |
|
| 2922504500 |
|
|
|
| USP-1473400 |
Norscopolamine (20 mg) ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate) |
4684-28-0 |
|
| 2933991200 |
|
|
|
| USP-1474005 |
Nortriptyline Hydrochloride (200 mg) |
894-71-3 |
|
| 2921490002 |
|
|
|
| USP-1474504 |
Noscapine (100 mg) |
128-62-1 |
|
| 2939190000 |
|
|
|
| USP-1475008 |
Novobiocin (200 mg) |
56677-21-5 |
|
| 2941906000 |
|
|
|
| USP-1477003 |
Nystatin (200 mg) (需冷链运输) |
1400-61-9 |
|
| 2941901010 |
|
|
|
| USP-1477604 |
Octreotide Acetate (4.37 mg) (需冷链运输) |
79517-01-4 |
|
| 2937190000 |
|
|
|
| USP-1477615 |
Octreotide Non-Cyclic System Suitability Marker (20 mg) (需冷链运输) |
774239-80-4 (Free base) |
|
| 2937190000 |
|
|
|
| USP-1478083 |
R-Ofloxacin (25 mg) ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
100986-86-5 |
|
| 2934990005 |
|
|
|
| USP-1478108 |
Ofloxacin (200 mg) |
82419-36-1 |
|
| 2934990005 |
|
|
|
| USP-1478119 |
Ofloxacin Related Compound A (25 mg) (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) |
82419-52-1 |
|
| 2934990005 |
|
|
|
| USP-1478141 |
Oleanolic Acid (15 mg) ((3beta)-3-hydroxyolean-12-en-28-oic acid) |
508-02-1 |
|
| 2918195000 |
|
|
|
| USP-1478163 |
Oleuropein (25 mg) |
32619-42-4 |
|
| 2938900000 |
|
|
|
| USP-1478196 |
Oleyl Stearate (50 mg) |
17673-50-6 |
|
| 2915700100 |
|
|
|
| USP-1478265 |
Olive Leaf Dry Extract (500 mg) |
8001-25-0 |
|
| 1302190200 |
|
|
|
| USP-1478301 |
Olanzapine (200 mg) |
132539-06-1 |
UN2811 |
| USP-1478312 |
Olanzapine Related Compound A (15 mg) (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile) |
138564-59-7 |
UN3077 |
| USP-1478323 |
Olanzapine Related Compound B (15 mg) (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one) |
221176-49-4 |
|
| 2934990005 |
|
|
|
| USP-1478367 |
Olmesartan Medoxomil (100 mg) |
144689-63-4 |
|
| 2934990005 |
|
|
|
| USP-1478378 |
Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) |
849206-43-5 |
|
| 2934990005 |
|
|
|
| USP-1478403 |
Olopatadine Hydrochloride (150 mg) |
140462-76-6 |
|
| 2932996560 |
|
|
|
| USP-1478425 |
Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide) |
173174-07-7 |
|
| 2932996560 |
|
|
|
| USP-1478436 |
Olopatadine Related Compound C (35 mg) (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl acetic acid) |
55453-87-7 |
UN2811 |
| USP-1478479 |
R-Omeprazole (15 mg) (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt) |
161796-77-6 |
|
| 2933399095 |
|
|
|
| USP-1478480 |
Omeprazole Related Compound B (15 mg) (5-Methoxy-1H-benzimidazol-2-thiol) |
37052-78-1 |
|
| 2933399095 |
|
|
|
| USP-1478491 |
Omeprazole Related Compound F and G Mixture (25 mg) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1048415 |
Lagerstroemia speciosa Leaf Dry Extract (1g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1048506 |
Beclomethasone Dipropionate (200 mg) |
5534/9/8 |
|
| 2937220000 |
|
|
|
| USP-1048517 |
Beclomethasone Dipropionate Related Compound A (25 mg) (9-Chloro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) |
69224-79-9 |
|
| 2918992090 |
|
|
|
| USP-1048543 |
Beclomethasone Dipropionate Related Compound H (25 mg) (9-Chloro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) |
5534-18-9 |
|
| 2918992090 |
|
|
|
| USP-1048550 |
Behenoyl Polyoxylglycerides (500 mg) |
N/A |
|
| 3824994100 |
|
|
|
| USP-1048572 |
Bemotrizinol (200 mg) |
187393-00-6 |
|
| 2933690000 |
|
|
|
| USP-1048583 |
Bemotrizinol Impurity Mixture (100 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1048619 |
Benazepril Hydrochloride (125 mg) |
86541-74-4 |
|
| 2933790002 |
|
|
|
| USP-1048620 |
Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) |
215447-89-5 |
|
| 2933790002 |
|
|
|
| USP-1048630 |
Benazepril Related Compound B (15 mg) (2-[(S)-3-{[(R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic acid hydrochloride) |
86541-77-7 |
|
| 2933790002 |
|
|
|
| USP-1048641 |
Benazepril Related Compound C (50 mg) ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid) |
86541-78-8 |
|
| 2933790002 |
|
|
|
| USP-1048652 |
Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride) |
N/A |
|
| 2933790002 |
|
|
|
| USP-1048663 |
Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride) |
N/A |
|
| 2933790002 |
|
|
|
| USP-1048674 |
Benazepril Related Compound F (15 mg) (tert-Butyl-3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid) |
109010-60-8 |
|
| 2933790002 |
|
|
|
| USP-1048685 |
Benazepril Related Compound G (15 mg) (需冷链运输) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester) |
103129-58-4 |
|
| 2933790002 |
|
|
|
| USP-1049000 |
Bendroflumethiazide (200 mg) |
73-48-3 |
|
| 2935904000 |
|
|
|
| USP-1050009 |
Benoxinate Hydrochloride (200 mg) |
5987-82-6 |
|
| 2922504500 |
|
|
|
| USP-1050982 |
Benzalkonium Bromide (C12) (150 mg) (Benzyldodecyldimethylammonium bromide) (需冷链运输) |
7281/4/1 |
UN2928 |
| USP-1051500 |
Benzethonium Chloride (500 mg) |
121-54-0 |
UN2923 |
| USP-1051602 |
Benzhydrol (50 mg) |
91-01-0 |
|
| 2906290000 |
|
|
|
| USP-1054000 |
Benzocaine (500 mg) |
1994/9/7 |
|
| 2922492050 |
|
|
|
| USP-1055002 |
Benzoic Acid (300 mg) |
65-85-0 |
UN3077 |
| USP-1056130 |
Benzophenone (25 mg) (Diphenylmethanone) |
119-61-9 |
UN3077 |
| USP-1056504 |
1,4-Benzoquinone (200 mg) |
106-51-4 |
UN2587 |
| USP-1057507 |
Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) |
121-30-2 |
|
| 2935909550 |
|
|
|
| USP-1059058 |
Benzphetamine Related Compound E (30 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-phenylpropan-1-ol hydrochloride) |
1591807-86-1 |
|
| 2922190900 |
|
|
|
| USP-1059069 |
Benzphetamine Related Compound F (25 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride) |
1591761-34-0 |
|
| 2922190900 |
|
|
|
| USP-1061027 |
Benztropine Related Compound A (50 mg) ((1R,3r,5S)-3-(Benzhydryloxy)-8-azabicyclo[3.2.1]octane hydrochloride) |
25471-67-4 |
|
| 2939800000 |
|
|
|
| USP-1062020 |
Benzyl Disulfide (200 mg) |
150-60-7 |
|
| 2930902000 |
|
|
|
| USP-1065209 |
Berberis aristata Stem Dry Extract (100 mg) |
NA |
|
| 1302190200 |
|
|
|
| USP-1065210 |
Berberine Chloride (50 mg) |
141433-60-5 |
|
| 2939790000 |
|
|
|
| USP-1065221 |
Bendamustine Hydrochloride (200 mg) |
3543-75-7 |
UN2811 |
| USP-1065232 |
Bendamustine Related Compound A (25 mg) (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride) |
109882-29-3 |
|
| 2933998350 |
|
|
|
| USP-1065243 |
Bendamustine Related Compound B (20 mg) (4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1065254 |
Bendamustine Related Compound C (20 mg) (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) |
3543-74-6 |
|
| 2933998350 |
|
|
|
| USP-1065265 |
Bendamustine Related Compound D (20 mg) (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride) |
1797881-48-1 |
|
| 2933998350 |
|
|
|
| USP-1065276 |
Bendamustine Related Compound E (20 mg) (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid) |
109882-27-1 |
|
| 2933997500 |
|
|
|
| USP-1065287 |
Bendamustine Related Compound F (20 mg) (Mannitol-1-yl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) |
1869075-89-7 |
|
| 2933998350 |
|
|
|
| USP-1065298 |
Bendamustine Related Compound G (20 mg) (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1065301 |
Bendamustine Related Compound H (25 mg) (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid) |
1228551-91-4 |
|
| 2933998350 |
|
|
|
| USP-1065312 |
Bendamustine Related Compound I (25 mg) (Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate) |
87475-54-5 |
|
| 2933998350 |
|
|
|
| USP-1065345 |
Methoxsalen Related Compound A (25 mg) (4-Methoxy-7H-furo[3,2-g]chromen-7-one) |
484-20-8 |
|
| 2932206000 |
|
|
|
| USP-1065550 |
Betadex Sulfobutyl Ether Sodium (500 mg) |
182410-00-0 |
|
| 2940006000 |
|
|
|
| USP-1065618 |
Betahistine Hydrochloride (200 mg) |
5579-84-0 |
|
| 2933399095 |
|
|
|
| USP-1065695 |
Betaine (1 g) |
107-43-7 |
|
| 2923900100 |
|
|
|
| USP-1065709 |
Betaine Hydrochloride (200 mg) |
590-46-5 |
|
| 2923900100 |
|
|
|
| USP-1066009 |
Betamethasone (200 mg) |
378-44-9 |
UN2811 |
| USP-1067001 |
Betamethasone Acetate (500 mg) |
987-24-6 |
UN2811 |
| USP-1067034 |
Betamethasone Acetate Related Compound C (20 mg) (9-Fluoro-11Beta,17,21-trihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 11,21-diacetate) |
330157-05-6 |
|
| 2918992090 |
|
|
|
| USP-1067045 |
Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate) |
912-38-9 |
|
| 2915399500 |
|
|
|
| USP-1067307 |
Betamethasone Benzoate (200 mg) |
22298-29-9 |
UN2811 |
| USP-1067704 |
Betamethasone Dipropionate (125 mg) |
5593-20-4 |
|
| 2937220000 |
|
|
|
| USP-1067726 |
Betamethasone Dipropionate Related Compound B (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) |
5534-13-4 |
|
| 2937220000 |
|
|
|
| USP-1067737 |
Betamethasone Dipropionate Related Compound C (25 mg) (9-Fluoro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) |
75883-07-7 |
|
| 2937220000 |
|
|
|
| USP-1067760 |
Betamethasone Dipropionate Related Compound F (30 mg) (9,11Beta-Epoxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) |
66917-44-0 |
|
| 2918992090 |
|
|
|
